Details for New Drug Application (NDA): 200892
✉ Email this page to a colleague
The generic ingredient in ETHOSUXIMIDE is ethosuximide. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the ethosuximide profile page.
Summary for 200892
Tradename: | ETHOSUXIMIDE |
Applicant: | Heritage Pharms Inc |
Ingredient: | ethosuximide |
Patents: | 0 |
Pharmacology for NDA: 200892
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Medical Subject Heading (MeSH) Categories for 200892
Suppliers and Packaging for NDA: 200892
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ETHOSUXIMIDE | ethosuximide | CAPSULE;ORAL | 200892 | ANDA | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-532 | 23155-532-01 | 100 CAPSULE in 1 BOTTLE (23155-532-01) |
ETHOSUXIMIDE | ethosuximide | CAPSULE;ORAL | 200892 | ANDA | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-532 | 23155-532-05 | 500 CAPSULE in 1 BOTTLE (23155-532-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
Approval Date: | Sep 25, 2012 | TE: | AB | RLD: | No |
Complete Access Available with Subscription